Feature | February 11, 2013

First Patient Treated Worldwide With The New CyberKnife M6 System

European CyberKnife Center to offer patients advanced radiosurgery treatments in Munich

Accuray Inc. European CyberKnife Center Munich-Grosshadern CyberKnife M6 System

February 11, 2013 — Accuray Inc. announced that the European CyberKnife Center Munich-Grosshadern (ECZM) has treated the world’s first patient with the new CyberKnife M6 System. With the installation of the new system, the Munich center, in close cooperation with the University Hospital of Munich, is the first to offer cancer patients treatment with the CyberKnife M6 System, the latest generation of the CyberKnife System. The new system is now able to provide enhanced quality, a streamlined user interface for treatment delivery and precision to radiation therapy treatments and continues to provide clinical capabilities including non-isocentric, non-coplanar robotic beam delivery and real-time tracking and automatic correction.

“We are pleased to have installed the first CyberKnife M6 System at the European CyberKnife Center Munich-Grosshadern,” said Joshua H. Levine, president and chief executive officer of Accuray Inc. “The CyberKnife M6 System is the next generation system and will enable clinicians to provide cancer patients with truly personalized treatments.”

The ECZM is a global pioneer in radiosurgery. Back in 2005, the center was the first in Germany to have installed a CyberKnife System. As of today, the team of clinicians has treated more than 3,500 patients for intra- and extracranial tumors using CyberKnife SBRT.

“It is vital to offer our patients the best possible care. With the CyberKnife System, we know from experience that extremely accurate outcomes can be achieved. The new system enables us to treat patients significantly faster. Also the treatment will be available to a much bigger patient population. With the CyberKnife Systems we are able to adapt the treatment accurately to the individual needs of each patient’s indication,” said Prof. Dr. Berndt Wowra, Neurosurgeon and Radiosurgeon.

Dr. Alexander Muacevic, Neurosurgeon, Radiosurgeon and president of the Radiosurgery Society, added: “We will now be able to not only treat small, well-circumscribed tumors, but also larger and irregularly-shaped target structures.”

For more information: www.cyber-knife.net/en.html

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Overlay Init